SUZHOU, China, May 9, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) announced today the successful completion of a $260 million (about RMB1.65 billion) financing, the largest Continue Reading
PRNews
CEDRUS Investments WILL launch a new office in Shenzhen
Expanding its Footprint in the Greater China Region and Capitalizing on Life Sciences Innovation and Hi-tech Investment Opportunities HONG KONG, May 9, 2018 /PRNewswire/ — Cedrus Continue Reading
Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future
RARITAN, New Jersey and SINGAPORE, May 8, 2018 /PRNewswire/ — Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, will host the Ortho Continue Reading
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
SHANGHAI, May 8, 2018 /PRNewswire/ — WuXi AppTec Co., Ltd. (“WuXi AppTec” or “the Company”; Stock Code: 603259), a leading global pharmaceutical and medical device Continue Reading
WuXi STA Changzhou Site Passes First U.S. FDA Inspection
The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval SHANGHAI, May 7, 2018 /PRNewswire/ — STA Pharmaceutical Continue Reading
Vieworks’ VIVIX-S N Series Receives CFDA Clearance
-By strengthening the wireless X-ray flat panel detector lineup, Vieworks is expecting to revamp sales in China ANYANG, South Korea and BEIJING, May 7, 2018 Continue Reading
Mundipharma licenses Starpharma’s VivaGel BV
– Mundipharma licenses Starpharma’s VivaGel® BV for Asia, Middle East, Africa and the majority of Latin America, to be marketed as part of the popular Continue Reading
CStone announces first patient dosed with anti-CTLA-4 antibody CS1002 of a Phase I study in Australia
SUZHOU, China, May 4, 2018 /PRNewswire/ — CStone Pharmaceuticals (Suzhou) Co., Ltd., (CStone) today announced dosing of the first patient of a Phase I clinical Continue Reading
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
Conference call to take place Friday, May 11, 2018 at 8:30 am Eastern time ISNES, Belgium, May 4, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) Continue Reading
China Biologic Reports Financial Results for the First Quarter of 2018
–1Q18 Total Sales Up 13.7% YoY and Non-GAAP Adjusted Net Income Up 2.1% YoY in RMB terms, or Total Sales Up 23.0% YoY to $112.5 Continue Reading